What is Brigatinib: Uses, Dosage, Side Effects and More

Brigatinib is a targeted cancer medication specifically designed to treat a certain type of lung cancer called ALK-positive non-small cell lung cancer. This prescription drug works by blocking specific proteins that help cancer cells grow and spread throughout your body.

If you or someone you care about has been prescribed brigatinib, you're likely looking for clear, trustworthy information about what to expect. Let's walk through everything you need to know about this medication in a way that feels manageable and reassuring.

What is Brigatinib?

Brigatinib belongs to a class of medications called kinase inhibitors, which are essentially targeted therapies for cancer. Think of it as a precision tool rather than a broad-spectrum treatment—it specifically targets cancer cells that have a particular genetic change called ALK rearrangement.

This medication comes as oral tablets that you take by mouth, making it more convenient than many traditional cancer treatments that require hospital visits for infusion. The drug was developed to be effective against lung cancer cells that have become resistant to other ALK inhibitors.

Your oncologist will typically prescribe brigatinib after confirming through genetic testing that your cancer has the ALK gene rearrangement. This personalized approach helps ensure you're getting the most appropriate treatment for your specific type of cancer.

What is Brigatinib Used For?

Brigatinib is primarily used to treat ALK-positive metastatic non-small cell lung cancer (NSCLC). This means it's prescribed for lung cancer that has spread to other parts of the body and contains specific genetic changes.

Your doctor might prescribe brigatinib as a first-line treatment if you've been newly diagnosed with ALK-positive lung cancer. Alternatively, it may be recommended if your cancer has progressed or stopped responding to other ALK inhibitors like crizotinib or ceritinib.

The medication is also being studied for other types of cancer that have ALK gene changes, though these uses are still considered experimental. Your oncologist will determine if brigatinib is appropriate based on your specific cancer type and genetic test results.

How Does Brigatinib Work?

Brigatinib works by blocking the ALK protein, which acts like a faulty switch that tells cancer cells to grow and multiply uncontrollably. By inhibiting this protein, the medication essentially turns off the signal that drives cancer growth.

This is considered a strong, targeted therapy because it specifically attacks the molecular pathway that's driving your cancer. Unlike traditional chemotherapy that affects both healthy and cancerous cells, brigatinib is designed to be more selective in its action.

The medication also has activity against certain mutations that can develop when cancer becomes resistant to other ALK inhibitors. This makes it particularly valuable for treating cancers that have evolved to evade other targeted therapies.

Most patients begin to see effects within the first few weeks of treatment, though the full benefit may take several months to become apparent on imaging studies.

How Should I Take Brigatinib?

Take brigatinib exactly as your oncologist prescribes, typically once daily with or without food. You can take it with a glass of water, and there's no specific requirement to take it with milk or avoid certain foods.

Swallow the tablets whole without crushing, chewing, or breaking them. If you have difficulty swallowing pills, talk to your healthcare team about strategies that might help, but don't alter the tablets on your own.

Try to take brigatinib at the same time each day to maintain consistent levels in your body. Many patients find it helpful to link taking their medication to a daily routine, like having breakfast or brushing their teeth.

You don't need to eat specific foods before taking brigatinib, but maintaining good nutrition throughout your treatment can help support your overall health and energy levels.

How Long Should I Take Brigatinib For?

You'll typically continue taking brigatinib for as long as it's effectively controlling your cancer and you're tolerating it well. This could be months or even years, depending on how your cancer responds to treatment.

Your oncologist will monitor your progress through regular scans and blood tests to determine if the medication is working effectively. These check-ups usually happen every few months, though the schedule may vary based on your individual situation.

Some patients continue brigatinib for extended periods with good cancer control and manageable side effects. Others may need to adjust their treatment plan if the cancer develops resistance or if side effects become problematic.

Never stop taking brigatinib without discussing it with your healthcare team first. Even if you're feeling well, stopping abruptly could allow your cancer to grow more rapidly.

What Are the Side Effects of Brigatinib?

Like all cancer medications, brigatinib can cause side effects, though many patients find them manageable with proper support and monitoring. Understanding what to expect can help you feel more prepared and confident about your treatment.

Here are the most common side effects that patients experience, affecting more than 20% of people taking brigatinib:

• Diarrhea, which can usually be managed with dietary changes and medications
• Fatigue or feeling more tired than usual
• Nausea, often manageable with anti-nausea medications
• Headache, typically mild to moderate
• Cough, which may be related to your lung condition or the medication
• Muscle and joint pain
• Swelling in your legs, ankles, or feet
• Shortness of breath

These common side effects are generally manageable, and your healthcare team can provide strategies to help minimize their impact on your daily life.

There are also some less common but more serious side effects that require immediate medical attention. While these affect fewer patients, it's important to be aware of them:

• Lung problems, including inflammation of the lungs (pneumonitis)
• High blood pressure that develops suddenly
• Slow heart rate or heart rhythm problems
• Severe muscle pain or weakness
• Vision changes, including blurred vision or light sensitivity
• Severe or persistent stomach pain
• Signs of pancreatitis, such as severe abdominal pain that may radiate to your back

Contact your healthcare provider immediately if you experience any of these more serious symptoms. Early intervention can often prevent complications and keep you safely on treatment.

Some rare but serious side effects include severe skin reactions and liver problems. Your doctor will monitor you regularly through blood tests to catch any issues early.

Who Should Not Take Brigatinib?

Brigatinib isn't suitable for everyone, and your oncologist will carefully evaluate whether it's safe for you based on your overall health and medical history. This assessment helps ensure you get the most benefit with the lowest risk.

You should not take brigatinib if you have a known allergy to the medication or any of its components. Your doctor will review your allergy history before prescribing this treatment.

People with certain heart conditions may need special monitoring or may not be candidates for brigatinib. This includes those with significant heart rhythm problems or severely reduced heart function.

If you have severe liver or kidney problems, your doctor may need to adjust your dose or consider alternative treatments. Regular monitoring becomes especially important in these situations.

Pregnant women should not take brigatinib as it can harm the developing baby. If you're of childbearing age, you'll need to use effective birth control during treatment and for some time after stopping the medication.

Brigatinib Brand Name

Brigatinib is sold under the brand name Alunbrig in the United States and many other countries. You may see either name on your prescription bottle or insurance paperwork.

The medication is manufactured by Takeda Pharmaceuticals, and it's the same active ingredient regardless of whether your prescription says "brigatinib" or "Alunbrig." Some insurance plans may have preferences for how they list the medication.

When discussing your medication with healthcare providers or pharmacists, you can use either name—they'll understand you're referring to the same drug.

Brigatinib Alternatives

Several other ALK inhibitors are available if brigatinib isn't suitable for you or if your cancer develops resistance. Your oncologist can help determine which option might work best for your specific situation.

Crizotinib (Xalkori) is often used as a first-line treatment for ALK-positive lung cancer. It was the first ALK inhibitor approved and has a well-established safety profile, though some cancers eventually develop resistance to it.

Ceritinib (Zykadia) is another option that may be effective against cancers that have become resistant to crizotinib. It has a different side effect profile, which might be preferable for some patients.

Alectinib (Alecensa) is considered very effective for ALK-positive lung cancer and may have fewer side effects than some other options. It's particularly good at treating cancer that has spread to the brain.

Lorlatinib (Lorbrena) is designed to overcome resistance to other ALK inhibitors and can effectively treat brain metastases. It represents one of the newest options in this class of medications.

Is Brigatinib Better Than Crizotinib?

Clinical studies suggest that brigatinib may be more effective than crizotinib, especially for patients whose cancer has spread to the brain or has developed resistance to other treatments. However, "better" depends on your individual situation and how you respond to treatment.

Brigatinib appears to control cancer progression for longer periods than crizotinib in many patients. It's also more effective at treating cancer that has spread to the brain, which is a common concern with ALK-positive lung cancer.

However, crizotinib has been used longer and has a more established safety profile. Some patients tolerate crizotinib better than brigatinib, particularly regarding certain side effects like high blood pressure.

Your oncologist will consider factors like your overall health, the extent of your cancer, previous treatments, and your personal preferences when recommending which medication might be most appropriate for you.